Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis-Reference-Cited by-全球学者库

Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis

Published:2023-09 Issue: Volume:955 Page:175915
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Zeng Jingran,Liang Liyin,Chen Rui,Li Chuting,Pan Linjie,Wen Min,Lv Dongxin,Liu Min,Xu Zhanchi,Huang Heqing

Funder

National Natural Science Foundation of China

Special Project for Research and Development in Key areas of Guangdong Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference54 articles.

1. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences;Burley;Nucleic Acids Res.,2021

2. The role of EMT in renal fibrosis;Carew;Cell Tissue Res.,2012

3. EGFR signaling promotes TGFbeta-dependent renal fibrosis;Chen;J. Am. Soc. Nephrol.,2012

4. Fraxin promotes the activation of Nrf2/ARE pathway via increasing the expression of Connexin43 to ameliorate diabetic renal fibrosis;Chen;Front. Pharmacol.,2022

5. The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders;Di Gregorio;Front. Cell Dev. Biol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22